Maldives Food and Drug Authority MFDA has banned the use and sale of three batches of Allegra suspension.
Allegra Suspension is usually given to children to treat a wide range of symptoms caused due to allergic conditions such as hay fever, urticaria (hives), conjunctivitis (red, itchy eye), and common cold.
MFDA said that the use and sale of the drug was suspended because quality issues had been detected in three batches of the drug.
It said that quality issues were detected from batch numbers, AL1223029, AL1223019, and AL1223060 of Allegra (30mg/15ml).
The drug is marketed by Sanofi India Ltd.
The MFDA said it had been alerted by the drug manufacturer to quality problems in three batches of Allegra and that it had banned the import, sale, and use of the three batches.
MFDA requested the distributors to notify it via email if the batches of the drug have been stocked at a pharmacy, drug store, or healthcare facility.
